Ligandrol (LGD-4033)

Ligandrol (LGD-4033) is a non-steroidal research compound investigated within the selective androgen receptor modulator (SARM) class. It is supplied strictly for laboratory research use only and is not intended for human or veterinary use. This listing is provided solely for qualified researchers requiring a well-characterised reference material for in-vitro and preclinical study.

Research Background

Ligandrol is widely referenced in laboratory research on androgen receptor selectivity. Investigations have examined its high binding affinity for the androgen receptor and the tissue-selective transcriptional responses that distinguish it from steroidal ligands within controlled preclinical and in-vitro systems. Its well-defined pharmacological profile has made it a common reference standard when characterising the behaviour of non-steroidal androgen receptor ligands.

Research on LGD-4033 typically focuses on receptor-binding kinetics, reporter-gene transcriptional assays, and comparative selectivity profiling across androgen-responsive cell lines. Investigators use it in structure-activity studies of the SARM class to explore how molecular features govern receptor affinity, functional selectivity, and the balance of activity across different androgen-responsive tissues. Researchers have paid particular attention to how binding within the receptor ligand-binding domain shapes coactivator recruitment and the resulting transcriptional profile observed in reporter assays, providing a framework for understanding non-steroidal receptor pharmacology in laboratory settings. Its consistent and well-documented behaviour has made LGD-4033 a frequent benchmark in reference panels, allowing investigators to calibrate assay sensitivity and confirm reproducibility across related non-steroidal ligands. This established profile makes it a dependable reagent for method development and comparative receptor-profiling work within androgen-signalling research programmes.

Ligandrol (LGD-4033) Specifications & Handling

• Purity: ≥99% as determined by analytical testing
• Verification: independent third-party HPLC and mass spectrometry, with a batch-specific Certificate of Analysis (COA) available for laboratory records
• Physical form: supplied as a laboratory-grade solution or fine powder depending on batch presentation
• Storage: store in a cool, dark environment; refrigerate solutions and protect from light and heat to preserve stability throughout the research period
• Handling: keep containers tightly sealed and handle using appropriate personal protective equipment in a suitable laboratory environment
• Documentation: batch COA available on request to support internal verification and traceability records

Related Research Compounds

Researchers studying androgen receptor selectivity may also wish to reference LGD-3303, RAD-140 (Testolone), and Ostarine (MK-2866), each of which is examined within overlapping receptor-selectivity frameworks. Browse the full range of research SARMs for additional reference materials and comparison compounds.

All SARMs listed are supplied strictly for in-vitro and laboratory research use only. They are not approved therapeutic goods and are not intended for human or veterinary use, diagnosis, treatment, or any performance or physique application. Researchers are responsible for ensuring full compliance with applicable Australian law and Therapeutic Goods Administration (TGA) regulations.

For laboratory and research use only. This product is not for human or veterinary consumption, and nothing on this page is medical advice. Researchers are responsible for compliance with all applicable Australian laws (including TGA regulations) and institutional guidelines.